Björn Schimmöller - Inorganic Chemistry at the Frontier of Immunotherapy (FODD #15)
Автор: Antiverse
Загружено: 2024-01-17
Просмотров: 217
Описание:
In this episode, we speak with Björn Schimmöller, Co-Founder and CEO of iuvantium, a synthetic immunobiology company developing new modalities for the next generation of immunotherapies.
Host: Murat Tunaboylu, Co-Founder and CEO of Antiverse.
You will learn:
The founding journey of iuvantium from Oxford University.
How iuvantium is enhancing immune system efficiency and reduce clinical trial uncertainty using inorganic chemistry.
‘Decoding’ the immune system and how personalised medicine may lead to the next leaps in immunotherapy.
Never miss a future event!
We'll notify you when a new event is scheduled. Fill out this form to sign up for marketing communications from Antiverse: https://share.hsforms.com/1ybacT57PSl...
We post about upcoming events on LinkedIn and Twitter.
LinkedIn: /
X: / antiversehq
Timestamps:
0:00 - Introduction to iuvantium
0:38 - Bjorn and iuvantium
1:34 - Founding story
5:30 - Fundraising and vision
9:18 - First applications (Vaccines)
12:02 - Boosting/Predicting immune responses
14:13 - Timelines and future concepts
19:15 - Closing thoughts
21:16 - Outro
Also available on all major podcasting platforms: https://open.spotify.com/episode/3e8D...
#FODD #immunotherapy #vaccine #startup
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
